COLUMBIA, Md., Nov. 20 /PRNewswire-FirstCall/ -- Martek Biosciences today announced the election of Harry J. D’Andrea to its Board of Directors. Mr. D’Andrea’s role on the Board of Directors will include membership on the Board’s Audit Committee.
Mr. D’Andrea is a co-founder and partner at Valhalla Partners, a Virginia- based venture capital firm that manages greater than $440 million in capital and invests primarily in technology companies. Mr. D’Andrea brings an extensive business background to Martek’s Board having served as chief financial officer for Yurie Systems, Inc., which was acquired by Lucent Technology in 1998, and several other technology companies over the past twenty years. Mr. D’Andrea also previously held a variety of positions with and gained valuable international business experience working at Marriott Corporation and Xerox Corporation.
Mr. D’Andrea holds a Masters in Business Administration from Drexel University and a Bachelor of Arts degree in Foreign Service and International Politics from The Pennsylvania State University. He is active in the greater Baltimore/Washington, D.C. area business community and has served in a variety of capacities for the Tech Council of Maryland and the University of Maryland’s Technology Advancement Program.
“We are pleased to welcome Harry D’Andrea to Martek’s board,” said Steve Dubin, CEO of Martek. “Harry’s leadership and financial experience with publicly-held technology companies will serve Martek well.”
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life’sDHA(TM), a sustainable vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.
CONTACT Cassie France-Kelly Public Relations (443) 542-2116 cfrancekelly@martek.com Kyle Stults Investor Relations (410) 740-0081 kstults@martek.com
Martek Biosciences Corporation
CONTACT: Cassie France-Kelly, Public Relations, +1-443-542-2116,cfrancekelly@martek.com or Kyle Stults, Investor Relations,+1-410-740-0081, kstults@martek.com, both of Martek Biosciences Corporation
Web site: http://www.martekbio.com//
